Clinical trial
SVF in Stage 3–4 Chronic Kidney Disease
Single intravenous SVF administration.
A registered trial means this question is still being studied. It is not evidence that the treatment works or is approved.
- Registry ID
- NCT04771122
- Status
- Active
- Phase
- Phase 1
- Sponsor
- Kyoto Regenerative Institute
- Country
- Japan
- Enrollment
- 24
- Study design
- Open-label safety study
- Start date
- 2024-09-02
- Est. completion
- 2026-10-31
- Last updated
- 2026-02-27
Inclusion criteria
- • eGFR 20–45 mL/min/1.73m²
Exclusion criteria
- • Currently on dialysis